Managing early Coat's disease requires careful staging. When the presentation falls within Shields stage 1 (retinal telangiectasia only) or stage 2 (telangiectasia with exudation) and the disease is not progressing, the evidence points to a distinct management pathway.
Clinical scenario: Coat's disease classified as Shields stage 1 (retinal telangiectasia only) or stage 2 (retinal telangiectasia with exudation), in the absence of documented disease progression. This mild presentation defines how the condition should be managed.
Approach: For mild Coat's disease at stage 1 or 2 without progression, the structured evidence-based approach involves a conservative strategy — the complete protocol specifies the applicable criteria, monitoring intervals, and decision points in full.
DOI: 10.1159/000336906
Mild disease (1, 2) without progression Observation – no treatment
View source ↗